What does Rhino Biotech Limited do?

Rhino Biotech Limited (RBRXF) operates in the Shell Companies industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.

What is RBRXF's market cap?

Rhino Biotech Limited (RBRXF) has a market capitalization of approximately $3,105, as of March 6, 2025, based on the most recent share price and shares outstanding.

Does RBRXF pay a dividend?

No — Rhino Biotech Limited (RBRXF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

RBRXF (Rhino Biotech Limited) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

RBRXF

Rhino Biotech Limited

OTC·Shell Companies · Financial Services

$0.00$0.00+9,900.00%

Market cap$3.11K·Market closed·Mar 6 8:00 PM UTC

Price Chart

$0.00+$0.00 (+9,900.00%)today

−99.33%CAGR −63.30%

Select date range

FromTo

Feb 4, 2005Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

RBRXF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how RBRXF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RBRXF and 80,000+ other tickers.

About Rhino Biotech Limited

Rhino Biotech Limited is dedicated to pioneering the development of health supplements sourced from plants and fungi, in addition to biopharmaceutical solutions designed for both disease prevention and treatment. The company adopted its current name, Rhino Biotech Limited, in September 2021, having previously operated as Eurasia Energy Limited. Established in 2003, its operations are based in South Hill, Anguilla.

CEO: Nicholas W. Baxter
Sector: Financial Services
Industry: Shell Companies
Exchange: OTC
Employees: 1
Website: ir.rhinobiotech.com

Peers

Peers Tab

SSCR

SMSA Crane Acquisition Corp.

Cap

$3.0K

WWSG

Worldwide Strategies, Inc.

Cap

$2.7K

PLYN

Palayan Resources, Inc.

Cap

$3.7K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About RBRXF

What does Rhino Biotech Limited do?: Rhino Biotech Limited (RBRXF) operates in the Shell Companies industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.
What is RBRXF's market cap?: Rhino Biotech Limited (RBRXF) has a market capitalization of approximately $3,105, as of March 6, 2025, based on the most recent share price and shares outstanding.
Does RBRXF pay a dividend?: No — Rhino Biotech Limited (RBRXF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.